Trademark: 90008197
Word
QVEQLI
Status
Pending
Status Code
733
Status Date
Thursday, November 16, 2023
Serial Number
90008197
Mark Type
4000
Filing Date
Thursday, June 18, 2020
Published for Opposition
Tuesday, September 21, 2021

Trademark Owner History

Classifications
9 Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases
5 Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment of infectious diseases; diagnostic preparations for medical purposes, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases
10 Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus for diagnostic purposes, namely, medicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic

Trademark Events
Nov 18, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 16, 2023
Sou Extension 4 Granted
Nov 16, 2023
Sou Extension 4 Filed
Nov 16, 2023
Sou Teas Extension Received
Nov 13, 2023
Assigned To Examiner
May 16, 2023
Notice Of Approval Of Extension Request E-Mailed
May 12, 2023
Sou Extension 3 Granted
May 12, 2023
Sou Extension 3 Filed
May 12, 2023
Sou Teas Extension Received
May 2, 2023
Assigned To Examiner
Nov 18, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 16, 2022
Sou Extension 2 Granted
Nov 16, 2022
Sou Extension 2 Filed
Nov 16, 2022
Sou Teas Extension Received
May 14, 2022
Notice Of Approval Of Extension Request E-Mailed
May 12, 2022
Sou Extension 1 Granted
May 12, 2022
Sou Extension 1 Filed
May 12, 2022
Sou Teas Extension Received
Nov 16, 2021
Noa E-Mailed - Sou Required From Applicant
Sep 21, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 21, 2021
Published For Opposition
Sep 1, 2021
Notification Of Notice Of Publication E-Mailed
Aug 17, 2021
Electronic Record Review Complete
Aug 13, 2021
On Hold - Electronic Record Review Required
Aug 12, 2021
Approved For Pub - Principal Register
Jul 13, 2021
Teas/Email Correspondence Entered
Jul 13, 2021
Correspondence Received In Law Office
Jul 9, 2021
Assigned To Lie
May 26, 2021
Teas Response To Suspension Inquiry Received
Apr 22, 2021
Notification Of Letter Of Suspension E-Mailed
Apr 22, 2021
Letter Of Suspension E-Mailed
Apr 22, 2021
Suspension Letter Written
Mar 22, 2021
Teas/Email Correspondence Entered
Mar 22, 2021
Correspondence Received In Law Office
Mar 22, 2021
Teas Response To Office Action Received
Sep 22, 2020
Notification Of Non-Final Action E-Mailed
Sep 22, 2020
Non-Final Action E-Mailed
Sep 22, 2020
Non-Final Action Written
Sep 22, 2020
Assigned To Examiner
Jul 16, 2020
New Application Office Supplied Data Entered
Jun 22, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24